Easton Silent on Progress of Cannabis Business

A year ago, in August 2017, Toronto-based specialty pharmaceutical company Easton Pharmaceuticals (OTC: EAPH), paid Canadian-based Alliance Group $1.3 million for an interest in 45 agriculturally zoned acres north of Toronto for the cultivation of cannabis.

Being such a large parcel for the cannabis industry—comprising almost 2 million sf—this was exciting news. If they develop this into cultivation, it could catapult Easton to being a large producer.

But a year later, little is being reported about the progress.

At the time, Alliance Partners was confident all hurdles to grow legalized medical/recreational marijuana would be cleared shortly, leading to production within 6 months from its first greenhouse facility. They expect it to generate several millions of dollars in its first year with good profit margins.

As of June 2018, it reported simply that Alliance was working on the property. No progress has since been reported. Until revenues are generated, Easton will receive 50% of all revenues from Alliance’s other businesses.

Easton’s investment and guarantee on revenues are securitized by Alliance’s larger 135-acre property, appraised at over $8,000,000. Easton retains the option to buy 50% of Alliance’s businesses, which include recycling, manufacturing of industrial products, and waste management with million dollar contracts in place.

Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in pharmaceutical sectors and other industries. It currently owns topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. These are in various stages of development.

Source Easton press release

Easton Silent on Progress of Cannabis Business

Cannin Investment Group: Your Hemp Stocks Experts

Cannin.com is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020.

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.

Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks

Easton Silent on Progress of Cannabis Business